|
![]() |
|
|||||||||||||||
|
|
|
|
|
|
| Time Table | |||
| Wednesday, May 24 | |||
| Teatro Comunale - Theatre Hall | |||
| 14.30 - 15.00 | Opening ceremony | ||
| Theatre Hall | The Ridotto | ||
| 15.00 - 18.20 | Symposium - Basic Pharmacology: Invited Lectures. | Symposium - Medicinal Chemistry: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 18.30 - 19.00 | Overview: R.A. North (Manchester, UK) | ||
| Porch of Castello Estense | |||
| 19.30 | Welcome Party | ||
| Thursday, May 25 | |||
| Theatre Hall | The Ridotto | ||
| 08.00 - 09.40 | Symposium - Cardiovascular System I: Invited Lectures. | Symposium - Bone and cartilage: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 09.40 - 10.05 | Coffee Break | ||
| Theatre Hall | The Ridotto | Ballet Room | |
| 10.05 - 11.20 | Symposium - Cardiovascular System II: Invited Lectures. | Symposium - Immunology and Inflammation: Invited Lectures. | Round Table - Caffeine and Health (beginning to 10.55). |
| 11.20 - 12.35 | Oral Presentations - Basic Pharmacology. | ||
| Teatro Comunale - Theatre Hall | |||
| 12.40 - 13.10 | Overview: S. Robson (Boston, USA) | ||
| 13.10 - 14.30 | Lunch | ||
| Theatre Hall | The Ridotto | ||
| 14.30 - 16.50 | Symposium - Respiratory System: Invited Lectures. | Symposium - Immunology and Inflammation: Invited Lectures (ends to 16.45). | |
| Teatro Comunale - Theatre Hall | |||
| 16.50 - 17.15 | Coffee Break | ||
| 17.15 - 18.00 | Robert M. Berne Award: B.B. Fredholm (Stockolm, Sweden) | ||
| Theatre Hall | The Ridotto | ||
| 18.00 - 19.30 | Oral Presentations - Respiratory and Cardiovascular Systems. | Oral Presentations - Immunology and Inflammation. | |
| Castello Estense | |||
| 08.00 - 19.30 | Poster Sessions: 1,2,3,4. | ||
| Teatro Comunale - Theatre Hall | |||
| 21.30 | Concert | ||
| Friday, May 26 | |||
| Theatre Hall | The Ridotto | ||
| 08.00 - 09.30 | Oral Presentations - Nervous System. | Oral Presentations - Cell Proliferation and Cancer. | |
| Teatro Comunale - Theatre Hall | |||
| 09.35 - 10.05 | Overview: J. Linden (Charlottesville, USA) | ||
| 10.05 - 10.35 | Coffee Break | ||
| 10.40 - 11.25 | Giuliana Fassina Award: L. Belardinelli (Palo Alto, USA) | ||
| Theatre Hall | The Ridotto | ||
| 11.30 - 12.45 | Symposium - Pain and Nerve Transmission: Invited Lectures. | Symposium - Cell Proliferation and Cancer: Invited Lectures. | |
| 13.00 - 14.30 | Lunch | ||
| 14.30 - 16.10 | Symposium - Pain and Nerve Transmission: Invited Lectures. | Symposium - Cell Proliferation and Cancer: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 16.10 - 16.30 | Coffee Break | ||
| 16.40 - 17.25 | Geoffrey Burnstock Lecture: H. Zimmermann (Frankfurt, Germany) | ||
| Theatre Hall | The Ridotto | ||
| 17.30 - 19.30 | Oral Presentations - Medicinal Chemistry and Basic Pharmacology. | Round Table - Non-Adenine Based Purines: Invited Lectures. | |
| Castello Estense | |||
| 08.00 - 19.30 | Poster Sessions: 5,6. | ||
| 20.30 | Social Dinner | ||
| Saturday, May 27 | |||
| Theatre Hall | The Ridotto | ||
| 08.00 - 10.05 | Symposium - Central Nervous System: Invited Lectures. | Symposium - Ecto-nucleotidases: Structure and Function: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 10.05 - 10.30 | Coffee Break | ||
| Theatre Hall | The Ridotto | ||
| 10.30 - 12.10 | Oral Presentations - Central Nervous System (beginning to 10.40). | Symposium - EctoATPases and metabolism: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 12.15 - 13.00 | Plenary Lecture: G. Burnstock (London, UK) | ||
| 13.00 - 14.30 | Lunch | ||
| Theatre Hall | The Ridotto | ||
| 14.30 - 16.35 | Symposium - Adenosine and Neuroprotection: Invited Lectures. | Symposium - Ecto-nucleotidases: Physiological Implications: Invited Lectures. | |
| Teatro Comunale - Theatre Hall | |||
| 16.35 - 16.55 | Coffee Break | ||
| 17.00 - 17.30 | Overview: P. Illes (Leipzig Germany) | ||
| Theatre Hall | The Ridotto | ||
| 17.40 - 18.25 | Oral Presentations - Central Nervous System. | 17.40 - 18.55 Symposium - Platelets: Invited Lectures. | |
| 18.30 - 19.30 | Oral Presentations - Basic and Applied Pharmacology. | 19.00 - 19.45 Oral Presentations - Basic and Applied Pharmacology. | |
| Castello Estense | |||
| 08.00 - 19.30 | Poster Sessions: 7,8,9,10. | ||
| Sunday, May 28 | |||
| Theatre Hall | The Ridotto | ||
| 08.00 - 10.00 | Oral Presentations - Clinical Pharmacology. | 19.00 - 19.45 Oral Presentations - Basic and Applied Pharmacology. | |
| Teatro Comunale - Theatre Hall | |||
| 10.00 - 10.20 | Coffee Break | ||
| 10.20 - 10.50 | Overview: B. Cronstein (New York, USA) | ||
| Theatre Hall | The Ridotto | ||
| 10.50 - 12.55 | Symposium - Nucleotide Receptors and Cellular Function. | Round Table - Purinome-based drugs. | |
| Teatro Comunale - Theatre Hall | |||
| 13.00 - 13.10 | Concluding Remarks | ||
| 13.10 - 14.30 | Lunch | ||
| Detailed programme | |||
| Wednesday, May 24 | |||
| Theatre Hall | |||
| 14.30 - 15.00 | Opening ceremony | ||
| Theatre Hall | The Ridotto | ||
| Basic Pharmacology - Chair: E. Lazarowski, J. Boyer. | Medicinal Chemistry - Chair: A.P. Ijzerman, P.G. Baraldi. | ||
| 15.00 - 15.25 | M. Diaz-Hernandez - Modulation of presynaptic P2X receptors by other neurotransmitter systems. | A. P. Ijzerman - Novel orthosteric and allosteric ligands for adenosine receptors. | |
| 15.25 - 15.50 | M. Idzkò - P2-Receptor mediated immune-responses: a link to asthmatic airway inflammation? | P. G. Baraldi - Recent developments in A2B and A3 adenosine receptor antagonists. | |
| 15.50 - 16.15 | R. J. Evans - Molecular physiology and pharmacology of P2X1 receptors. | J. Zablocki - The discovery of selective high affinity A2B adenosine receptor antagonists. | |
| 16.15 - 16.40 | E. Lazarowski - Release of nucleotides and UDP-sugars from airway epithelia. | M. Botta - Synthesis and molecular modeling studies of new pyrazolo[3,4-b]pyridines, potent and selective inhibitors of A1 adenosine receptors. | |
| Basic Pharmacology - Chair: A. Ribeiro, M. T. Miras-Portugal. | Medicinal Chemistry - Chair: K.A. Jacobson, G. Cristalli. | ||
| 16.40 - 17.05 | J.Pintor - Role of diadenosine polyphosphates on corneal wound healing. | K. A. Jacobson - Molecular recognition in P2Y nucleotide receptors. | |
| 17.05 - 17.30 | A. Surprenant - New insight into P2X7 receptor signaling. | G. Cristalli - New nucleotides and nucleotides analogs and their activity on P2 Receptors. | |
| 17.30 - 17.55 | G. A. Weisman - Novel Signal Transduction Pathways Regulated by P2Y2 Nucleotide Receptors Mediate Inflammatory Responses in Mammalian Cells. | C. E. Muller - Development of pharmacological tools for studying P2Y receptors. | |
| 17.55 - 18.20 | T. K. Harden - Quantification and agonist-promoted regulation of the P2Y1 receptor. | P. S. Watson - Adenine nucleotides as reversible P2Y12 antagonists. | |
| Theatre Hall | |||
| Overview: Chair: F. Di Virgilio | |||
| 18.30 - 19.00 | R. A. North - Structure and function of P2X receptors. | ||
| Porch of Castello Estense | |||
| 19.30 | Welcome Party | ||
| Thursday, May 25 | |||
| Theatre Hall | The Ridotto | ||
| Cardiovascular System I - Chair: L. Belardinelli, R. D. Lasley. | Bone and cartilage - Chair: J. A. Gallagher, T. Arnett. | ||
| 08.00 - 08.25 | L. Kuo - Adenosine and vasomotor regulation in the coronary microcirculation. | J. A. Gallagher - Integrating local and systemic regulation of bone turnover though P2 receptor signalling. | |
| 08.25 - 08.50 | T. H. Adair - An emerging role for adenosine in angiogenesis. | T. Arnett - P2Y nucleotide receptor function in osteoblasts. | |
| 08.50 - 09.15 | G. A. Rongen - The forearm model as a tool to study the clinical pharmacology of adenosine in humans. | S. J. Dixon - P2X7 nucleotide receptor functions in bone cells. | |
| 09.15 - 09.40 | R. D. Lasley - Subcellular aspects of adenosine receptor-mediated signaling in ventricular myocardium. | N. R. Jorgensen - The role of nucleotides and P2 receptors in intercellular signaling in bone. | |
| 09.40 - 10.05 | Coffee Break | Coffee Break | |
| Cardiovascular System II - Chair: A. Pelleg, J. Headrick. | Immunology and Inflammation - Chair: J. Linden, B. Cronstein. | ||
| 10.05 - 10.30 | A. Deussen - Control of extracellular adenosine concentration by ecto-5' nucleotidase. | E. Chan - Adenosine in dermal and hepatic fibrosis. | |
| 10.30 - 10.55 | S. J. Mustafa - Molecular mechanisms of coronary flow regulation by adenosine. | M. Sitkovsky - From "Hellstrom paradox" to Redox-Adenosinergic Rule of Immune Response. | |
| 10.55 - 11.20 | R. Rosso - Use of adenosine compounds for identifying patients prone to suffer from tachyarrhythmias. |
Ballet Room Round Table on Caffeine and Health - Chair: B. Fredholm, S. Garattini, E. Illy. |
M. R. Blackburn - Adenosine receptors and the regulation of chronic lung disease. |
| Basic Pharmacology - F. Caciagli, J. Boyer. |
Opening Remarks:
S. Garattini. Discussants: W. R. Lovallo -Caffeine effects on blood pressure and stress responses in persons at risk for developing hypertension. A. Nehlig - Caffeine and headache: an update. J. M. Vaugeois, M. El. Yacoubi - The effects of caffeine on anxiety- and mood-related behaviors in mice. Closing Remarks: S. Garattini, B.B. Fredholm, E. Illy. |
||
| 11.25 - 11.50 |
Oral Presentations |
M. D. Okusa - Adenosine A2A agonists in renal tissue protection. | |
| 11.50 - 12.15 | J. D. Powell - Tissue-derived adenosine promotes peripheral T cell tolerance by Stimulating the A2A receptor. | ||
| 12.15 - 12.35 | |||
| Theatre Hall | |||
| Overview: Chair: H. Zimmerman | |||
| 12.40 - 13.10 | Simon Robson - The ecto-nucleotidase CD39/NTPDase1 is a key modulator of vascular inflammation and immunity. | ||
| 13.10 - 14.30 | Lunch | ||
| Theatre Hall | The Ridotto | ||
| Respiratory System - Chair: I. Biaggioni, L. Belardinelli. | Immunology and Inflammation - Chair: F. Koch-Nolte, M. Sitkovsky. | ||
| 14.30 - 14.40 | L. Belardinelli - Opening remarks. | ||
| 14.40 - 15.05 | I. Feoktistov - Role of adenosine receptors in regulation of pro-inflammatory and pro-angiogenic cytokines in mast cells. | J. S. Wiley - Polymorphisms in the P2X7 receptor and their clinical associations. | |
| 15.05 - 15.30 | D. Zeng - Inflammatory role of adenosine in human lung cells. | R. Coutinho-Silva - P2 receptors: Role on host defense against intracellular microorganisms. | |
| 15.30 - 15.55 | R. C. Boucher - Airway epithelial ATP release and airway surface hydration in health and disease. | F. Koch-Nolte - Activation of P2X7 by ADP-ribosylation. | |
| 15.55 - 16.20 | S. P. Colgan - Coordinated nucleotide metabolism and vascular leak. | D. Communi - Target genes of extracellular ATP in human dendritic cells. | |
| 16.20 - 16.45 | R. Polosa - Adenosine: a promising clinical indicator of inflammation in asthma. | M. Seman - ADP-ribosylation by ARTs introduces diacritic modifications in the cytokine network. | |
| 16.45 - 16.50 | I. Biaggioni - Closing remarks. | ||
| 16.50 - 17.15 | Coffee Break | Coffee Break | |
| Theatre Hall | |||
| Berne Award - Chair: J. Linden. | |||
| 17.15 - 18.00 | B. B. Fredholm - Targeting adenosine receptors. | ||
| Theatre Hall | The Ridotto | ||
| Respiratory and Cardiovascular Systems - Chair: C. N. Wilson, S. J. Mustafa. | Immunology and Inflammation - Chair: F. Haag, J. Auchampach. | ||
| 18.00 - 19.40 | Oral presentations | Oral presentations | |
| Theatre Hall | |||
| 21.30 | Social Event: Gino Neri Orchestra (Typical Italian Music). Site web | ||
| Friday, May 26 | |||
| Theatre Hall | The Ridotto | ||
| Nervous System - Chair: C. Volontè, M. Morelli. | Cell Proliferation and Cancer - Chair: A. Minelli, L. Erb. | ||
| 08.00 - 09.30 | Oral presentations | Oral presentations | |
| Theatre Hall | |||
| Overview - Chair: M. Sitkowski. | |||
| 09.35 - 10.05 | Joel Linden - Activation of adenosine A2A receptors on CD4+ T cells reduces reperfusion injury. | ||
| 10.05 - 10.35 | Coffee Break | ||
| Giuliana Fassina Award - Chair: P. A. Borea. | |||
| 10.40 - 11.25 | Luiz Belardinelli - Therapeutic potential of partial A1 agonists in insulin resistance and diabetes. | ||
| Theatre Hall | The Ridotto | ||
| Pain and Nerve Transmission - Chair: K. Inoue, P. Illes. | Cell Proliferation and Cancer - Chair: F. Di Virgilio, P. Dagnelie. | ||
| 11.30 - 11.55 | K. Inoue - P2X4-dependent neuropathic pain: a mechanism of the facilitation in pain transmission via microglia. | P. Dagnelie - ATP: a new treatment modality in cancer? | |
| 11.55 - 12.20 | A. Nistri - Expression, function and modulation of P2X3 receptors on trigeminal ganglion nociceptors. | F. Di Virgilio - P2X7: a growth-promoting receptor. | |
| 12.20 - 12.45 | I. P. Chessel - The role of P2X7 and P2X4 in pain processing: common or divergent pathways? | J. T. Neary - Regulation of astrocyte proliferation by P2Y and P2X purinergic receptors. | |
| 13.00 - 14.30 | Lunch | ||
| Theatre Hall | The Ridotto | ||
| Pain and Nerve Transmission - Chair: K. Inoue, P. Illes. | Cell Proliferation and Cancer - Chair: P. Fishman, P. A. Borea. | ||
| 14.30 - 14.55 | K. Biber - Adenosine receptors in astrocytes, cytokines and neuroprotection. | P. Fishman - Targeting the A3 adenosine receptor to combat cancer and autoimmune inflammatory diseases. | |
| 14.55 - 15.20 | C. Verderio - Functional consequences of P2X7 activation in astrocytes and microglial cells. | S. Bar-Yehuda - Inhibition of hepatocellular carcinoma growth by an A3 adenosine receptor agonist: De-regulation of PKB/Akt-NF-kB signaling pathway. | |
| 15.20 - 15.45 | A. M. F. Sebastiao - Adenosine regulation of neurotrophin synaptic actions. | Lak Shin Jeong - Design, synthesis and antitumor activity of 4'-thionucleosides as highly potent and selective A3 adenosine receptor agonists. | |
| 15.45 - 16.10 | S. Kohsaka - Intracellular signalling underlying ATP-induced chemotaxis of microglia. | S. Merighi - Growth regulation of tumor cells in hypoxia: focus on A3 adenosine receptors. | |
| 16.10 - 16.30 | Coffee Break | Coffee Break | |
| Theatre Hall | |||
| Burnstock Lecture - Chair: G. Burnstock | |||
| 16.40 - 17.25 | Herbert Zimmermann - Versatile messengers in the brain: nucleotide storage, signaling and hydrolysis. | ||
| Theatre Hall | The Ridotto | ||
| Medicinal Chemistryand Basic Pharmacology - Chair: S. Vittori, G. Reiser. | Round Table on Non-Adenine Based Purines - Chair: F. Caciagli, M. P. Rathbone. | ||
| 17.30 - 17.50 | Oral presentations | M. P. Rathbone - Evidence for a patho-physiological and pharmacological role of guanine-based purines as a new extracellular signalling system. | |
| 17.50 - 18.10 | D. O. Souza - The guanine-based purinergic system as a new target for neuroprotection against glutamatergic excitotoxicity. | ||
| 18.10 - 18.30 | S. Jiang - Guanosine stimulates remyelination in injured spinal cord through promotion of proliferation and differentiation of oligodendroglial precursor cells. | ||
| 18.30 - 18.50 | P. L. Ipata - The role of uridine kinase and uridine phosphorylase in the cross regulation of uracil and adenine nucleotides salvage synthesis in rat and human brain. | ||
| 18.50 - 19.10 | G. G. Yegutkin - Metabolism of extracellular nucleotides and nucleosides in the vasculature. | ||
| 19.10 - 19.30 | F. Caciagli - Towards a patho-physiological role of non adenine purine nucleobases in the Central Nervous System. | ||
| 20.30 | Social Dinner | ||
| Saturday, May 27 | |||
| Theatre Hall | The Ridotto | ||
| Central Nervous System - Chair: M. P. Abbracchio, R. A. Cunha. | Ecto-nucleotidases: Structure and Function - Chair: M. Bollen, G. Guidotti. | ||
| 08.00 - 08.25 | M. Abbracchio - P2 receptors in glial cells. | G. Guidotti - The transmembrane domains of E-NTPDase 1, CD39, regulate its enzymatic activity. | |
| 08.25 - 08.50 | R. A. Cunha - Presynaptic P2 receptors - Interaction with other receptors and role in neuroprotection. | T. L. Kirley - Progress on the structures and functions of nucleoside triphosphate diphosphohydrolases and a calcium activated nucleotidase. | |
| 08.50 - 09.15 | R. D. Fields - Purinergic signaling in regulating myelination by action potentials. | M. Bollen - Contibution of NPP-type ectophosphodiesterases to extracellular nucleotide metabolism. | |
| 09.15 - 09.40 | P. Haydon - Purinergic coordination of synaptic cross-talk mediated by astrocytes. | M. Takedachi - CD73-deficient mice show increased lymphocyte migration through high endothelial venules (HEV) in draining lymph nodes during inflammation. | |
| 09.40 - 10.05 | L. Galliresta - Extracellular ATP mediates rapid retinal ganglion cell injury induced by intraocular pressure spikes. | ||
| 10.05 - 10.30 | Coffee Break | Coffee Break | |
| Central Nervous System - Chair: F. Pedata, P. Popoli. | EctoATPases and Metabolism - Chair: T. L. Kirley, J. Sevigny. | ||
| 10.30 - 10.55 | Oral Presentations | J. Sevigny - Co-ordinated regulation of P2-receptors signaling by membrane bound NTPDases. | |
| 10.55 - 11.20 | J. Straeter - Structure and function of ecto-5'-nucleotidase based on structural studies of the bacterial 5'-nucleotidases. | ||
| 11.20 - 11.45 | J. L. Millàn - The key regulators of skeletal mineralization: TNAP, NPP1 and ANK as therapeutic targets for the treatment of osteoarthritis, hypophosphatasia and arterial calcification. | ||
| 11.45 - 12.10 | S. P. Colgan - Ecto-5’-nucleotidase (CD73) and mucosal inflammation. | ||
| Theatre Hall | |||
| Plenary Lecture - Chair: F. Di Virgilio. | |||
| 12.10 - 12.55 | Geoffrey Burnstock - Purinergic signalling: past, present and future | ||
| 13.00 - 14.30 | Lunch | ||
| Theatre Hall | The Ridotto | ||
| Adenosine and neuro protection - Chair: B. B. Fredholm, J. F - Chen. | Ecto-nucleotidases: Physiological Implications - Chair: S. Robson, H. Zimmermann. | ||
| 14.30 - 14.55 | J. F. Chen - Adenosine A2A receptors modulate psychomotor activity and brain injury by distinct cellular mechanisms. | S. Deaglio - Ectoenzymes of CD38 and CD39 gene families catalyze immunomodulation. | |
| 14.55 - 15.20 | R. Franco - Adenosine receptor-receptor interactions: relevance for ischemia and caffeine tolerance. | F. Malavasi - CD38/CD157 gene family in health and disease. | |
| 15.20 - 15.45 | Y. Chern - Adenosine and Huntington's disease. | J. Schrader - Role of CD73-derived adenosine in acute and chronic inflammation. | |
| 15.45 - 16.10 | T. Kanda - Adenosine A2A receptors and Parkinson's disease - Effects of Istradefylline on functional models of Parkinson’s disease. | M. Picher, L. H. Burch - Biphasic regulation of airway E-NTPDases by "Pseudomonas Aeruginosa" Lipopolysaccharide. | |
| 16.10 - 16.35 | I. Diamond - A2A adenosine receptors regulate CNS responses to ethanol and addicting substances: recent advances from cell biology to behavior. | D. J. Pinsky - to be announced. | |
| 16.35 - 16.55 | Coffee Break | Coffee Break | |
| Theatre Hall | |||
| Overview - Chair: A. North. | |||
| 17.00 - 17.30 | Peter Illes - P2X and P2Y receptor-involvement in pain sensation; possible targets for new analgesics. | ||
| Theatre Hall | The Ridotto | ||
| Central Nervous System - Chair: C. Verderio, R. Ciccarelli. | Platelets - Chair: M. Cattaneo, C. Gachet. | ||
| 17.40 - 18.05 | Oral Presentations | M. Cattaneo - Congenital and drug-induced P2Y12 defects in the clinical setting. | |
| 18.05 - 18.30 | C. Gachet - P2Y1 and P2X1 as targets for new anti-platelet agent. | ||
| Basic and Applied Pharmacology - Chair: J. Pintor, U. Traversa. | |||
| 18.30 - 18.55 | Oral Presentations | M. Mahaut-Smith - Purinoceptor-evoked signalling via P2X1 and other ion channels in the platelet. | |
| 18.55 - 19.30 | Basic and Applied Pharmacology - Chair: S. Ceruti, E. Kaczmarek. | ||
| 19.00 - 19.45 | Oral Presentations | ||
| Sunday, May 28 | |||
| Theatre Hall | The Ridotto | ||
| Clinical Pharmacology - Chair: D. Spina, B. Hechler. | Basic and Applied Pharmacology - Chair: C. Martini, S. Hourani. | ||
| 08.00 - 10.00 | Oral Presentations | Oral Presentations | |
| 10.00 - 10.20 | Coffee Break | Coffee Break | |
| Theatre Hall | |||
| Overview - Chair: M. P. Abbracchio. | |||
| 10.20 - 10.50 | Bruce Cronstein - A Fuller Quiver - Adenosine receptors as therapeutic targets. | ||
| Theatre Hall | The Ridotto | ||
| Nucleotide Receptors and Cellular Function - Chair: J Schrader, E. Schwiebert. | Round Table: Purinome-based drugs - Chair: M. Williams, S. Bhagwat. | ||
| 10.50 - 11.15 | J. Jankowski - Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor.. | Discussants: Steve Hall - Beyond purinergic receptors: drugging the rest of the purine-binding proteome. Alan J. Lewis - Kinases: important drug targets for novel anti-inflammatory therapies. Carlos Garcia-Echeverria - Challenges and opportunities in the identification of insulin-like growth factor-I receptor kinase inhibitors. David G. Barrett - Allosteric activators of glucokinase: the development of cyclopropane-derived agents and their potential for use in the treatment of type two diabetes. |
|
| 11.15 - 11.40 | E. M. Schwiebert - Co-secretion and autocrine signaling of ATP, zinc and other mediators in epithelial and non-epithelial cell models: dynamic and minute-to-minute regulation of cell physiology. | ||
| 11.40 - 12.05 | I. Novak - P2Y and P2X receptors and their role in exocrine pancreas. | ||
| 12.05 - 12.30 | D. Erlinge - Cardiovascular ATP release: Focus on the red blood cell. | ||
| 12.30 - 12.55 | N. Dale - Purinergic signalling triggers development of the eye. | ||
| Theatre Hall | |||
| 13.00 - 13.10 | Concluding Remarks - P. A. Borea. | ||
| 13.10 - 14.30 | Lunch | ||
| Poster sessions will be held in Castello Estense like described in Time Table. | |||